Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 13, 2024
Associations of Prostate Tumor Immune Landscape with Vigorous Physical Activity and Prostate Cancer ProgressionLanshan Huang, Sarah J Winter, Linnea T Olsson, et al.
Journal for Immunotherapy of Cancer|October 25, 2023
PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesotheliomaKrisztian Homicsko, Panagiota Zygoura, Maxim Norkin, et al.
Nature Communications|September 6, 2017
Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancerSvitlana Tyekucheva, Michaela Bowden, Clyde Bango, et al.
Nature Biotechnology|December 23, 2008
Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapyJinyan Du, Paula Bernasconi, Karl R Clauser, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2026
Impact of TP53, KEAP1 and STK11 mutations in localized-stage NSCLC: A European thoracic oncology platform lungscape projectMiguel A Molina-Vila, Zoi Tsourti, Katerina Vervita, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 1, 2021
Prognostic Impact of KRAS G12C Mutation in Patients With NSCLC: Results From the European Thoracic Oncology Platform Lungscape ProjectStephen P Finn, Alfredo Addeo, Urania Dafni, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2014
Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus PanelJohn M Fitzpatrick, Joaquim Bellmunt, Karim Fizazi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2019
Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate CancerEmma H Allott, Ericka M Ebot, Konrad H Stopsack, et al.
Pageof 12